Imaging for assessment of sudden death risk: current role and future prospects.

Sudden cardiac death (SCD) remains a major public health problem and there is an urgent need to maximize the impact of primary prevention using the implantable defibrillator. While implantable defibrillators are of utility for prevention of SCD, current methods of selecting candidates have significant shortcomings. Major advancements have occurred in the field of cardiac imaging, with significant potential to identify novel cardiac substrates for improved prediction. While assessment of the left ventricular ejection fraction remains the current major predictor, it is likely that several novel imaging markers will be incorporated into future risk stratification approaches. The goal of this review is to discuss the current status and future potential of cardiac imaging modalities to enhance risk stratification for SCD.

[1]  Jeroen J. Bax,et al.  The relationship between time from myocardial infarction, left ventricular dyssynchrony, and the risk for ventricular arrhythmia: speckle-tracking echocardiographic analysis. , 2015, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[2]  C. Kramer,et al.  Prognostic value of late gadolinium enhancement in clinical outcomes for hypertrophic cardiomyopathy. , 2012, JACC. Cardiovascular imaging.

[3]  S. Chugh,et al.  Prediction of sudden cardiac death: next steps in pursuit of effective methodology , 2011, Journal of Interventional Cardiac Electrophysiology.

[4]  James O. Mudd,et al.  T1 Mapping in cardiomyopathy at cardiac MR: comparison with endomyocardial biopsy. , 2012, Radiology.

[5]  D. Mozaffarian,et al.  Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[6]  J. Svendsen,et al.  Strain echocardiography improves risk prediction of ventricular arrhythmias after myocardial infarction. , 2013, JACC. Cardiovascular imaging.

[7]  É. Marijon,et al.  Frequency and Determinants of Implantable Cardioverter Defibrillator Deployment Among Primary Prevention Candidates With Subsequent Sudden Cardiac Arrest in the Community , 2013, Circulation.

[8]  S. Dorbala,et al.  Selected review article based on ASNC meeting presentationIntegrated cardiac PET-CT for the diagnosis and management of CAD , 2006 .

[9]  Laurie Zoloth,et al.  Risk Stratification for Sudden Cardiac Death: A Plan for the Future , 2014, Circulation.

[10]  G. Korosoglou,et al.  T1 mapping in dilated cardiomyopathy with cardiac magnetic resonance: quantification of diffuse myocardial fibrosis and comparison with endomyocardial biopsy. , 2015, European heart journal cardiovascular Imaging.

[11]  B. Lindsay,et al.  ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, Ameri , 2013, Journal of the American College of Cardiology.

[12]  Raymond J Kim,et al.  Frontiers in cardiovascular magnetic resonance. , 2005, Circulation.

[13]  A. Taylor,et al.  Diffuse myocardial fibrosis in severe aortic stenosis: an equilibrium contrast cardiovascular magnetic resonance study. , 2012, European heart journal cardiovascular Imaging.

[14]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, Circulation.

[15]  James E. Muller,et al.  Detection of lipid core coronary plaques in autopsy specimens with a novel catheter-based near-infrared spectroscopy system. , 2008, JACC. Cardiovascular imaging.

[16]  K. Reinier,et al.  Increased left ventricular mass and decreased left ventricular systolic function have independent pathways to ventricular arrhythmogenesis in coronary artery disease. , 2011, Heart rhythm.

[17]  Richard D. White,et al.  ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. , 2010, Circulation.

[18]  A. Castellanos,et al.  Interpretation of outcomes of antiarrhythmic clinical trials: design features and population impact. , 1998, Circulation.

[19]  C. Albert,et al.  Implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: too little and too late? , 2013, Circulation.

[20]  M. Hori,et al.  Prediction of sudden death in patients with mild-to-moderate chronic heart failure by using cardiac iodine-123 metaiodobenzylguanidine imaging , 2007, Heart.

[21]  M. Phelps,et al.  PET: the merging of biology and imaging into molecular imaging. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[22]  Ruben Coronel,et al.  Activation Delay After Premature Stimulation in Chronically Diseased Human Myocardium Relates to the Architecture of Interstitial Fibrosis , 2001, Circulation.

[23]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2010 update: a report from the American Heart Association. , 2010, Circulation.

[24]  M. Cerqueira,et al.  Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. , 2010, Journal of the American College of Cardiology.

[25]  H. Wellens,et al.  Out-of-hospital cardiac arrest--the relevance of heart failure. The Maastricht Circulatory Arrest Registry. , 2003, European heart journal.

[26]  Wojciech Zareba,et al.  Diagnosis of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia: Proposed Modification of the Task Force Criteria , 2010, European heart journal.

[27]  H. Dargie,et al.  Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. , 1987, The New England journal of medicine.

[28]  M. Travin,et al.  Radionuclide imaging of cardiac autonomic innervation , 2010, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[29]  A. Tajik,et al.  Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.

[30]  K. Reinier,et al.  Epidemiology of sudden cardiac death: clinical and research implications. , 2008, Progress in cardiovascular diseases.

[31]  R C Barr,et al.  Electrophysiological effects of remodeling cardiac gap junctions and cell size: experimental and model studies of normal cardiac growth. , 2000, Circulation research.

[32]  P R Ershler,et al.  Myocardial electrical propagation in patients with idiopathic dilated cardiomyopathy. , 1993, The Journal of clinical investigation.

[33]  P. Kellman,et al.  Association Between Extracellular Matrix Expansion Quantified by Cardiovascular Magnetic Resonance and Short-Term Mortality , 2012, Circulation.

[34]  David A Bluemke,et al.  T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA , 2012, Journal of Cardiovascular Magnetic Resonance.

[35]  Gregg W Stone,et al.  Detection of Lipid-Core Plaques by Intracoronary Near-Infrared Spectroscopy Identifies High Risk of Periprocedural Myocardial Infarction , 2011, Circulation. Cardiovascular interventions.

[36]  R. Mitchell,et al.  Quantification of Cardiomyocyte Hypertrophy by Cardiac Magnetic Resonance: Implications for Early Cardiac Remodeling , 2013, Circulation.

[37]  Jianhua Yao,et al.  Interstitial myocardial fibrosis assessed as extracellular volume fraction with low-radiation-dose cardiac CT. , 2012, Radiology.

[38]  H. Brunner,et al.  Congenital anomalies of the coronary arteries: imaging with contrast-enhanced, multidetector computed tomography , 2005, European Radiology.

[39]  Andrew S Flett,et al.  Comprehensive Validation of Cardiovascular Magnetic Resonance Techniques for the Assessment of Myocardial Extracellular Volume , 2013, Circulation. Cardiovascular imaging.

[40]  K. Dimopoulos,et al.  Left Ventricular Longitudinal Function Predicts Life-Threatening Ventricular Arrhythmia and Death in Adults With Repaired Tetralogy of Fallot , 2012, Circulation.

[41]  Udo Sechtem,et al.  Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. , 2010, Journal of the American College of Cardiology.

[42]  Michael Jerosch-Herold,et al.  Role of Transcytolemmal Water-Exchange in Magnetic Resonance Measurements of Diffuse Myocardial Fibrosis in Hypertensive Heart Disease , 2013, Circulation. Cardiovascular imaging.

[43]  Jagat Narula,et al.  Imaging vulnerable plaque by ultrasound. , 2006, Journal of the American College of Cardiology.

[44]  R. Mohiaddin,et al.  Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies , 2012, Journal of Cardiovascular Magnetic Resonance.

[45]  Katja Zeppenfeld,et al.  Infarct Tissue Heterogeneity Assessed With Contrast-Enhanced MRI Predicts Spontaneous Ventricular Arrhythmia in Patients With Ischemic Cardiomyopathy and Implantable Cardioverter-Defibrillator , 2009, Circulation. Cardiovascular imaging.

[46]  M. Majmudar,et al.  Cardiovascular Molecular Imaging: The Road Ahead , 2012, The Journal of Nuclear Medicine.

[47]  C. White,et al.  Anomalous coronary arteries in adults: depiction at multi-detector row CT angiography. , 2005, Radiology.

[48]  Katherine C. Wu,et al.  Infarct Tissue Heterogeneity by Magnetic Resonance Imaging Identifies Enhanced Cardiac Arrhythmia Susceptibility in Patients With Left Ventricular Dysfunction , 2007, Circulation.

[49]  Stephan G Nekolla,et al.  Cardiovascular molecular imaging: an overview. , 2009, Cardiovascular research.

[50]  M. Robson,et al.  Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement , 2013, Journal of Cardiovascular Magnetic Resonance.

[51]  Takashi Morita,et al.  Cardiac iodine-123 metaiodobenzylguanidine imaging predicts sudden cardiac death independently of left ventricular ejection fraction in patients with chronic heart failure and left ventricular systolic dysfunction: results from a comparative study with signal-averaged electrocardiogram, heart rate v , 2009, Journal of the American College of Cardiology.

[52]  M. Sheppard,et al.  Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy using cardiovascular magnetic resonance , 2010 .

[53]  C. O'connor,et al.  Single-photon emission computed tomography myocardial perfusion imaging and the risk of sudden cardiac death in patients with coronary disease and left ventricular ejection fraction>35%. , 2010, Journal of the American College of Cardiology.

[54]  Karen L. Gunson,et al.  Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. , 2006, Journal of the American College of Cardiology.

[55]  Antonio Berruezo,et al.  3D delayed-enhanced magnetic resonance sequences improve conducting channel delineation prior to ventricular tachycardia ablation. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[56]  E. Saloux,et al.  Scar extent as a predictive factor of ventricular tachycardia cycle length after myocardial infarction: implications for implantable cardioverter-defibrillator programming optimization. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[57]  A. Curtis,et al.  Regional myocardial sympathetic denervation predicts the risk of sudden cardiac arrest in ischemic cardiomyopathy. , 2014, Journal of the American College of Cardiology.

[58]  T. Nakata,et al.  Impaired Cardiac Sympathetic Innervation and Myocardial Perfusion Are Related to Lethal Arrhythmia: Quantification of Cardiac Tracers in Patients with ICDs , 2010, The Journal of Nuclear Medicine.

[59]  S. Heymans,et al.  Myocardial scar predicts monomorphic ventricular tachycardia but not polymorphic ventricular tachycardia or ventricular fibrillation in nonischemic dilated cardiomyopathy. , 2015, Heart rhythm.

[60]  Hirofumi Anno,et al.  Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. , 2009, Journal of the American College of Cardiology.

[61]  K. Croce,et al.  Optical Coherence Tomography , 2012, Circulation.

[62]  Jacques Ohayon,et al.  Detection of high-risk atherosclerotic plaque: report of the NHLBI Working Group on current status and future directions. , 2012, JACC. Cardiovascular imaging.

[63]  T. Nakata,et al.  I-123 MIBG imaging and heart rate variability analysis to predict the need for an implantable cardioverter defibrillator , 2003, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[64]  Mark E. Anderson,et al.  Sudden Cardiac Death Prediction and Prevention: Report From a National Heart, Lung, and Blood Institute and Heart Rhythm Society Workshop , 2010, Circulation.

[65]  R. Ruiz-Granell,et al.  Value of Early Cardiovascular Magnetic Resonance for the Prediction of Adverse Arrhythmic Cardiac Events After a First Noncomplicated ST-Segment–Elevation Myocardial Infarction , 2013, Circulation. Cardiovascular imaging.

[66]  Yasunori Ueda,et al.  Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy. , 2006, Journal of the American College of Cardiology.

[67]  Tevfik F Ismail,et al.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. , 2013, JAMA.

[68]  Ralph Weissleder,et al.  Molecular imaging of cardiovascular disease. , 2007, Circulation.

[69]  Sergio Waxman,et al.  Update on coronary angioscopy: review of a 20-year experience and potential application for detection of vulnerable plaque. , 2006, Journal of interventional cardiology.

[70]  Warren J Manning,et al.  Clinical Profile and Significance of Delayed Enhancement in Hypertrophic Cardiomyopathy , 2008, Circulation. Heart failure.

[71]  G. Breithardt,et al.  Cardiac Autonomic Dysfunction in Brugada Syndrome , 2002, Circulation.

[72]  Ralph Weissleder,et al.  Molecular and cellular imaging of atherosclerosis: emerging applications. , 2006, Journal of the American College of Cardiology.

[73]  J. Piccini,et al.  Single-Photon Emission Computed Tomography Myocardial Perfusion Defects Are Associated With an Increased Risk of All-Cause Death, Cardiovascular Death, and Sudden Cardiac Death , 2008, Circulation. Cardiovascular imaging.

[74]  D. Bluemke,et al.  3D left ventricular extracellular volume fraction by low-radiation dose cardiac CT: assessment of interstitial myocardial fibrosis. , 2013, Journal of cardiovascular computed tomography.

[75]  R. Blankstein,et al.  Quantification of coronary flow reserve in patients with ischaemic and non-ischaemic cardiomyopathy and its association with clinical outcomes. , 2015, European heart journal cardiovascular Imaging.

[76]  Akiko Maehara,et al.  A prospective natural-history study of coronary atherosclerosis. , 2011, The New England journal of medicine.

[77]  P. Stone,et al.  Circadian variation and triggers of onset of acute cardiovascular disease. , 1989, Circulation.

[78]  P. Kistler,et al.  Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death. , 2011, Journal of the American College of Cardiology.

[79]  A. Moss,et al.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. , 1996, The New England journal of medicine.

[80]  Brett E. Bouma,et al.  In Vivo Characterization of Coronary Atherosclerotic Plaque by Use of Optical Coherence Tomography , 2005, Circulation.

[81]  Chun Yuan,et al.  In Vivo Quantitative Measurement of Intact Fibrous Cap and Lipid-Rich Necrotic Core Size in Atherosclerotic Carotid Plaque: Comparison of High-Resolution, Contrast-Enhanced Magnetic Resonance Imaging and Histology , 2005, Circulation.

[82]  P. Mangin,et al.  Postmortem imaging of sudden cardiac death , 2013, International Journal of Legal Medicine.

[83]  S. Chugh Early identification of risk factors for sudden cardiac death , 2010, Nature Reviews Cardiology.

[84]  Jeroen J. Bax,et al.  Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy. , 2010, The American journal of cardiology.

[85]  P. Willeit,et al.  Left Ventricular Mass and the Risk of Sudden Cardiac Death: A Population‐Based Study , 2014, Journal of the American Heart Association.

[86]  Sabino Iliceto,et al.  Three-Dimensional Electroanatomic Voltage Mapping Increases Accuracy of Diagnosing Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2005, Circulation.

[87]  Robert G. Weiss,et al.  Magnetic Resonance Assessment of the Substrate for Inducible Ventricular Tachycardia in Nonischemic Cardiomyopathy , 2005, Circulation.

[88]  J. Gillard,et al.  Noninvasive imaging of carotid plaque inflammation , 2004, Neurology.

[89]  D. Corrado,et al.  Prognostic Value of Endocardial Voltage Mapping in Patients With Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia , 2013, Circulation. Arrhythmia and electrophysiology.

[90]  M. Fishbein,et al.  Characteristics of wave fronts during ventricular fibrillation in human hearts with dilated cardiomyopathy: role of increased fibrosis in the generation of reentry. , 1998, Journal of the American College of Cardiology.

[91]  E. Cook,et al.  Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy , 2014, Circulation.

[92]  K. Lee,et al.  A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators. , 1999, The New England journal of medicine.

[93]  M. D. Di Carli,et al.  Integrated cardiac PET-CT for the diagnosis and management of CAD. , 2006, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[94]  C. Tracy,et al.  American College of Cardiology Clinical Expert Consensus Document on Standards for Acquisition, Measurement and Reporting of Intravascular Ultrasound Studies (IVUS). A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. , 2001, Journal of the American College of Cardiology.

[95]  R. Virmani,et al.  Pathology of the Vulnerable Plaque , 2006 .

[96]  M. Hayward,et al.  Equilibrium Contrast Cardiovascular Magnetic Resonance for the Measurement of Diffuse Myocardial Fibrosis: Preliminary Validation in Humans , 2010, Circulation.

[97]  J. Silva-Cardoso,et al.  Cardiac 123I-MIBG scintigraphy and arrhythmic risk in left ventricular noncompaction. , 2012, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[98]  Sanjiv J Shah,et al.  Spironolactone for heart failure with preserved ejection fraction. , 2014, The New England journal of medicine.

[99]  Ciprian Catana,et al.  Performance test of an LSO-APD detector in a 7-T MRI scanner for simultaneous PET/MRI. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[100]  Katherine C. Wu,et al.  Late gadolinium enhancement by cardiovascular magnetic resonance heralds an adverse prognosis in nonischemic cardiomyopathy. , 2008, Journal of the American College of Cardiology.

[101]  T. Edvardsen,et al.  Mechanical dispersion by strain echocardiography: a predictor of ventricular arrhythmias in subjects with lamin A/C mutations. , 2015, JACC. Cardiovascular imaging.

[102]  A. Uy‐Evanado,et al.  Electrocardiographic versus echocardiographic left ventricular hypertrophy and sudden cardiac arrest in the community. , 2014, Heart rhythm.

[103]  H. Wellens,et al.  Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival. , 1997, Journal of the American College of Cardiology.

[104]  D. Pennell,et al.  Prognostic role of CMR in patients presenting with ventricular arrhythmias. , 2013, JACC. Cardiovascular imaging.

[105]  Andrea Mazzanti,et al.  [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death]. , 2015, Kardiologia polska.

[106]  S. Chugh,et al.  Gadolinium-enhanced magnetic resonance imaging for detection and quantification of fibrosis in human myocardium in vitro , 2007, The International Journal of Cardiovascular Imaging.

[107]  M. Janse,et al.  Fractionated electrograms in dilated cardiomyopathy: origin and relation to abnormal conduction. , 1996, Journal of the American College of Cardiology.

[108]  D. Levy,et al.  Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. , 1998, Journal of the American College of Cardiology.

[109]  M. Travin,et al.  Use of cardiac radionuclide imaging to identify patients at risk for arrhythmic sudden cardiac death , 2012, Journal of Nuclear Cardiology.

[110]  Titus Kuehne,et al.  Assessment of Diffuse Myocardial Fibrosis in Rats Using Small-Animal Look-Locker Inversion Recovery T1 Mapping , 2011, Circulation. Cardiovascular imaging.